The FDA has approved a third biosimilar for tocilizumab, called Avtozma, the second such biosimilar to be available in both ...

Avtozma, the third biosimilar to Actemra, has received FDA approval for multiple inflammatory diseases and COVID-19, potentially expanding treatment access for patients.

A diabetes drug may beat costly shots for patients with a rare genetic condition, according to a Rutgers Health study.

Takeda Canada Inc. (Takeda) is pleased to announce that Héma-Québec has added HyQvia®– (normal immunoglobulin [human] 10% and ...

Kashiv Biosciences, LLC, a global leader in biopharmaceutical innovation, today announced that their abatacept biosimilar ...

Bob Dylan earns his fortieth career hit on Billboard's Americana/Folk Albums chart as Mixing Up The ... [+] Medicine / A Retrospective debuts. April 1965: American electric folk hero Bob Dylan ...

Fonseca is nothing short of a physical freak Leading American tennis commentator and former coach Brad Gilber wrote on X Fonseca’s hitting was “off the charts” — having taken the title ...

As you might have understood by now, top legal torrent sites only host completely legal content and they do not indulge themselves in the act of piracy or copyright infringement. You won’t find the ...

Serina’s POZ technology is engineered to provide greater control in drug loading and more precision in the rate of release of attached drugs delivered via subcutaneous injection. The therapeutic ...

The subcutaneous autoinjector, named lecanemab-irmb, is designed as a weekly treatment option for maintenance dosing in patients who have already completed the biweekly intravenous initiation phase.